2 completed, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Unknown 1 |
Follow Menstrual Pain: new trials by email Literature Review of Menstrual Pain trials Research Report on Menstrual Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-Steroidal Anti-Inflammatory Drug (NSAID) Response and Central Sensitization of Pain in Women With Dysmenorrhea Sodium Naproxen, Placebo - Dysmenorrhea, Menstrual Pain | Phase 4 | Completed | Mclean Hospital | 70 | 2024-03-25 | 2026-09-22 |
| Effectiveness of PEA Compared to Placebo on Acute Menstrual Pain Levagen+, Microcrystalline cellulose - Menstrual Pain | Phase 4 | Completed | RDC Clinical Pty Ltd | 80 | 2023-05-19 | 2024-11-14 |
| Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis GnRH analog (11.25mg Leuprolide acetate), Aromatase inhibitor and GnRH analog, Aromatase and GnRH analog (11.25mg Leuprolide acetate) - Uterine Adenomyosis, Recurrent Implantation Failure | Phase 4 | Unknown | Centre for Endocrinology and Reproductive Medicine, Italy | 300 | 2017-12-01 | 2024-03-06 |
Dysmenorrhea (3) · Adenomyosis (1)
Menstruation Disturbances (3) · Neurologic Manifestations (3) · Pain (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Pelvic Pain (3) · Signs and Symptoms (3) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Urogenital Diseases (1) · Uterine Diseases (1)
Aromatase (1) · Aromatase Inhibitors (1) · Control Groups (1) · Gonadotropin-Releasing Hormone (1) · Leuprolide (1) · Naproxen (1) · microcrystalline cellulose (1)
Centre for Endocrinology and Reproductive Medicine, Italy (1) · Mclean Hospital (1) · RDC Clinical Pty Ltd (1)
Albania (1) · Australia (1) · Bulgaria (1) · Italy (1) · United States (1)
Amanda Rao, PhD (1) · Laura Payne, PhD (1)